EOLS – Evolus, Inc.
Evolus, Inc. Common StockEOLS
$10.04Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $647,335,040.00
EPSttm : -0.89
Evolus, Inc. Common Stock
$10.04
3.08%$0.3Float Short %
16.23
Margin Of Safety %
Put/Call OI Ratio
0.01
EPS Next Q Diff
0.19
EPS Last/This Y
0.68
EPS This/Next Y
0.71
Price
10.02
Target Price
23.57
Analyst Recom
1
Performance Q
-26.07
Relative Volume
1.33
Beta
0.99
Ticker: EOLS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | EOLS | 10.09 | 0.04 | 0.03 | 16958 |
| 2025-05-09 | EOLS | 9.78 | 0.04 | 0.06 | 17935 |
| 2025-05-12 | EOLS | 9.99 | 0.04 | 0.00 | 17966 |
| 2025-05-13 | EOLS | 10.15 | 0.04 | 0.00 | 18043 |
| 2025-05-14 | EOLS | 10.01 | 0.04 | 0.00 | 18113 |
| 2025-05-15 | EOLS | 10 | 0.04 | 0.02 | 18131 |
| 2025-05-16 | EOLS | 9.7 | 0.04 | 1.38 | 18059 |
| 2025-05-19 | EOLS | 9.9 | 0.01 | 0.46 | 14657 |
| 2025-05-20 | EOLS | 9.95 | 0.01 | 0.25 | 14717 |
| 2025-05-21 | EOLS | 9.61 | 0.01 | 0.53 | 14727 |
| 2025-05-22 | EOLS | 9.48 | 0.01 | 0.00 | 14825 |
| 2025-05-23 | EOLS | 9.69 | 0.01 | 999.99 | 14835 |
| 2025-05-27 | EOLS | 9.79 | 0.01 | 0.00 | 14845 |
| 2025-05-28 | EOLS | 9.31 | 0.01 | 0.00 | 14890 |
| 2025-05-29 | EOLS | 9.34 | 0.01 | 0.10 | 15147 |
| 2025-05-30 | EOLS | 9.19 | 0.01 | 0.00 | 15232 |
| 2025-06-02 | EOLS | 9.97 | 0.01 | 0.00 | 15730 |
| 2025-06-03 | EOLS | 9.98 | 0.01 | 999.99 | 15889 |
| 2025-06-04 | EOLS | 9.8 | 0.01 | 0.00 | 15894 |
| 2025-06-05 | EOLS | 9.73 | 0.01 | 0.00 | 15938 |
| 2025-06-06 | EOLS | 10.05 | 0.01 | 0.00 | 16006 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | EOLS | 10.09 | -30.6 | 12.8 | -0.12 |
| 2025-05-09 | EOLS | 9.78 | -30.6 | 10.6 | -0.06 |
| 2025-05-12 | EOLS | 9.98 | -30.6 | 9.6 | -0.06 |
| 2025-05-13 | EOLS | 10.13 | -18.9 | 5.7 | -0.06 |
| 2025-05-14 | EOLS | 10.00 | -18.9 | 12.4 | -0.06 |
| 2025-05-15 | EOLS | 10.00 | -18.9 | 12.1 | -0.06 |
| 2025-05-16 | EOLS | 9.70 | -18.9 | 12.8 | -0.06 |
| 2025-05-19 | EOLS | 9.90 | -42.6 | 11.7 | -0.13 |
| 2025-05-20 | EOLS | 9.97 | -42.6 | 12.0 | -0.13 |
| 2025-05-21 | EOLS | 9.59 | -42.6 | 13.0 | -0.13 |
| 2025-05-22 | EOLS | 9.57 | -42.6 | 12.2 | -0.13 |
| 2025-05-23 | EOLS | 9.70 | -42.6 | 11.8 | -0.13 |
| 2025-05-27 | EOLS | 9.81 | -42.6 | 11.8 | -0.13 |
| 2025-05-28 | EOLS | 9.30 | -42.6 | 13.3 | -0.13 |
| 2025-05-29 | EOLS | 9.34 | -42.6 | 12.0 | -0.13 |
| 2025-05-30 | EOLS | 9.19 | -42.6 | 12.5 | -0.13 |
| 2025-06-02 | EOLS | 9.94 | -42.6 | 10.3 | -0.13 |
| 2025-06-03 | EOLS | 9.96 | -42.6 | 12.2 | -0.13 |
| 2025-06-04 | EOLS | 9.80 | -42.6 | 12.5 | -0.13 |
| 2025-06-05 | EOLS | 9.74 | -42.6 | 12.3 | -0.13 |
| 2025-06-06 | EOLS | 10.02 | -42.6 | 11.4 | -0.13 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | EOLS | -2.30 | 5.27 | 13.49 |
| 2025-05-09 | EOLS | -2.30 | 5.27 | 13.49 |
| 2025-05-12 | EOLS | -2.30 | 4.94 | 15.36 |
| 2025-05-13 | EOLS | -2.30 | 4.94 | 15.36 |
| 2025-05-14 | EOLS | -2.30 | 4.94 | 15.36 |
| 2025-05-15 | EOLS | -2.62 | 4.94 | 15.36 |
| 2025-05-16 | EOLS | -2.62 | 4.94 | 15.36 |
| 2025-05-19 | EOLS | -2.62 | 8.63 | 15.35 |
| 2025-05-20 | EOLS | -2.63 | 8.63 | 15.35 |
| 2025-05-21 | EOLS | -2.63 | 8.63 | 15.35 |
| 2025-05-22 | EOLS | -2.63 | 8.63 | 15.35 |
| 2025-05-23 | EOLS | -2.63 | 8.63 | 15.35 |
| 2025-05-27 | EOLS | -2.63 | 3.10 | 15.35 |
| 2025-05-28 | EOLS | -2.63 | 3.10 | 16.23 |
| 2025-05-29 | EOLS | -2.63 | 3.10 | 16.23 |
| 2025-05-30 | EOLS | -2.63 | 3.10 | 16.23 |
| 2025-06-02 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-03 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-04 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-05 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-06 | EOLS | -2.63 | 5.51 | 16.23 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.25
Avg. EPS Est. Current Quarter
-0.09
Avg. EPS Est. Next Quarter
-0.06
Insider Transactions
-2.63
Institutional Transactions
5.51
Beta
0.99
Average Sales Estimate Current Quarter
82
Average Sales Estimate Next Quarter
85
Fair Value
Quality Score
33
Growth Score
55
Sentiment Score
79
Actual DrawDown %
43.8
Max Drawdown 5-Year %
-68.4
Target Price
23.57
P/E
Forward P/E
17.75
PEG
P/S
2.35
P/B
P/Free Cash Flow
EPS
-0.89
Average EPS Est. Cur. Y
-0.13
EPS Next Y. (Est.)
0.58
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-20.4
Relative Volume
1.33
Return on Equity vs Sector %
827
Return on Equity vs Industry %
843.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
11.4
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 372
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading